I. Bjorkhem, Five decades with oxysterols, vol.95, pp.448-454, 2013.

E. Fahy, S. Subramaniam, R. C. Murphy, M. Nishijima, C. R. Raetz et al., Update of the LIPID MAPS comprehensive classification system for lipids, J. Lipid Res, vol.50, pp.9-14, 2009.

G. J. Schroepfer, Oxysterols: modulators of cholesterol metabolism and other processes, Physiol. Rev, vol.80, pp.361-554, 2000.

M. Poirot and S. Silvente-poirot, Cholesterol-5,6-epoxides: chemistry, biochemistry, metabolic fate and cancer, Biochimie, vol.95, pp.622-631, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00743461

W. J. Griffiths and Y. Wang, Sterolomics: state of the art, developments, limitations and challenges, Biochim. Biophys. Acta, 2017.

S. Silvente-poirot, F. Dalenc, and M. Poirot, The effects of cholesterol-derived oncometabolites on nuclear receptor function in cancer, Cancer Res, vol.78, pp.4803-4808, 2018.

A. A. Kandutsch, H. W. Chen, and H. J. Heiniger, Biological activity of some oxygenated sterols, Science, vol.201, pp.498-501, 1978.

A. Wyss, T. Raselli, N. Perkins, F. Ruiz, G. Schmelczer et al., The EBI2-oxysterol axis promotes the development of intestinal lymphoid structures and colitis, Mucosal Immunol, vol.12, pp.733-745, 2019.

X. Ma, E. Bi, Y. Lu, P. Su, C. Huang et al., Cholesterol induces CD8(+) t cell exhaustion in the tumor microenvironment, Cell Metab, vol.30, pp.143-156, 2019.

K. R. Beck, S. Kanagaratnam, D. V. Kratschmar, J. Birk, H. Yamaguchi et al., Enzymatic interconversion of the oxysterols 7beta,25-dihydroxycholesterol and 7-keto,25-hydroxycholesterol by 11beta-hydroxysteroid dehydrogenase type 1 and 2, J. Steroid Biochem. Mol. Biol, vol.190, pp.19-28, 2019.

M. Voisin, P. Medina, A. Mallinger, F. Dalenc, E. Huc-claustre et al., Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptor, Proc. Natl. Acad. Sci. U. S. A, vol.114, pp.9346-9355, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02316171

G. Segala, M. David, P. Medina, M. C. Poirot, N. Serhan et al., Nat. Commun, vol.8, p.1903, 2017.

E. V. Dang, J. G. Mcdonald, D. W. Russell, and J. G. Cyster, Oxysterol restraint of cholesterol synthesis prevents AIM2 inflammasome activation, Cell, vol.171, pp.1057-1071, 2017.

A. E. Baek, Y. A. Yu, S. He, S. E. Wardell, C. Y. Chang et al., The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells, Nat. Commun, vol.8, p.864, 2017.

N. Sever, R. K. Mann, L. Xu, W. J. Snell, C. I. Hernandez-lara et al., Endogenous B-ring oxysterols inhibit the Hedgehog component Smoothened in a manner distinct from cyclopamine or side-chain oxysterols, Proc. Natl. Acad. Sci. U. S. A, vol.113, 2016.

F. R. Santori, P. Huang, S. A. Van-de-pavert, E. F. Douglass, D. J. Leaver et al., Identification of natural RORgamma ligands that regulate the development of lymphoid cells, Cell Metab, vol.21, pp.286-298, 2015.

L. Gabitova, D. Restifo, A. Gorin, K. Manocha, E. Handorf et al., Endogenous sterol metabolites regulate growth of EGFR/KRAS-Dependent tumors via LXR, Cell Rep, vol.12, pp.1927-1938, 2015.

P. Soroosh, J. Wu, X. Xue, J. Song, S. W. Sutton et al., Oxysterols are agonist ligands of RORgammat and drive Th17 cell differentiation, Proc. Natl. Acad. Sci. U. S. A, vol.111, pp.12163-12168, 2014.

S. Silvente-poirot and M. Poirot, the balance, vol.343, pp.1445-1446, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-00968924

E. R. Nelson, S. E. Wardell, J. S. Jasper, S. Park, S. Suchindran et al., 27-Hydroxycholesterol links hypercholesterolemia and breast cancer pathophysiology, vol.342, pp.1094-1098, 2013.

P. Medina, M. R. Paillasse, G. Segala, M. Voisin, L. Mhamdi et al., Dendrogenin A arises from cholesterol and histamine metabolism and shows cell differentiation and anti-tumour properties, Nat. Commun, vol.4, p.1840, 2013.
URL : https://hal.archives-ouvertes.fr/inserm-00823974